North America Ready-to-use Therapeutic Food Market was worth USD XX million in 2020, so it is estimated to reach USD XX million by 2026, growing at a CAGR of XX%. Therapeutic ready-to-use food provides malnourished kids with the necessary nutritional requirements to recuperate very rapidly and extensively. Moreover, since it should not be combined with water, it is reliable to leverage in isolated areas polluted water. Therefore, market players are engaged in developing and introducing novel nutrient compositions in a variety of formats. Also, these firms are coordinating with government and non-government organizations to assist in the successful allocation of ready-to-use therapeutic food.
Recent Developments
Market Growth
Drivers
Growing malnourishment issues all around the world are expected to drive the market expansion of ready-to-use therapeutic food. In addition, burgeoning government and non-governmental organization (NGO) efforts to treat malnutrition are anticipated to drive the market. For example, the collaborative efforts between the Global Health and Human Rights (GHHR), the Harvard College Global Hunger Initiative (GHI), and Karoli Lwanga Nyakibale Hospital in Rukungiri District, Uganda, led to the Initiative to End Child Malnutrition (IECM). As a result, the expansion of such efforts is likely to boost the demand for ready-to-use therapeutic food products. In addition, increasing the adoption of ready-to-use therapeutic food (RUTF) in the health industry is another aspect projected to drive industry growth in the coming years.
Restraints
The growing government trend toward local ingredients is projected to hamper RUFT industry expansion. For example, the UNICEF Standard RUTF formula contains substances such as milk powder, peanut, oils, vitamins, and minerals, and in most places, peanut and milk powder are not cost-effective.
As a result, to develop RUTF goods, local manufacturers and governments favor cost-effective replacements for peanuts and milk powder. This aspect is predicted to limit the expansion of the ready-to-use therapeutic food market. Furthermore, many readily available therapeutic food products manufacturers do not adhere to World Health Organization (WHO) food production standards, resulting in microbial spoilage.
RUFT products are too expensive to employ for anything more than the treatment of severe malnourishment, and their availability is heavily reliant on quick funding sources for disaster or relief operations. This aspect is projected to impede the development of the ready-to-use therapeutic food market in the coming years.
Market Segmentation
The North America Ready-to-use Therapeutic Food Market is segmented based on Product Type.
By Type
The market is segmented into solid, semi-solid, and drinkable liquids.
The semi-solid paste sector is predicted to stay dominant during the assessment period and increase at a rapid CAGR. Semi-solid items are in high demand since they do not need to be mixed with water, and the risk of contaminated water in distant places is significant, leading to various ailments. Semi-solid diets are being developed, and companies broaden their offerings to meet the growing demand for malnourished children.
In addition, companies are attempting to create new low-cost goods that deliver superior nutrition. Following UNICEF's announcement of expanded buying of drinking RUTFs, the drinkable RUTF category is expected to overgrow.
Solid RUTFs are accessible as powder, cookies, and chocolate bars, which can be eaten directly from the package or blended with water to make porridge. Because of the industry's consistent demand for solid items, it is forecasted to see a wide range of product development, leading to faster market expansion.
The growing demand for drinkable RUTF products is likely to fuel the expansion of the ready-to-use therapeutic food industry. Because it is challenging to feed RUTF paste to infants to treat malnutrition, this factor is expected to increase the demand for drinkable RUTF products such as therapeutic milk. As a result, newborns are more interested in drinkable RUFT products, fueling the rise of the ready-to-use therapeutic food sector.
Regional Analysis
Ready-to-use Therapeutic Food Market in North America is divided into three regions: the United States, Canada, and Mexico. North America is expected to increase at a high double-digit rate during the evaluation period. This is because maximum manufacturing facilities are sophisticated enough and are now being expanded. In the United States, the Ready-to-Use Therapeutic Food industry is expected to be worth US$108.2 million in 2021.
Canada is expected to increase at a 7.7 percent annual rate during the analysis period. The United Nations Children's Fund (UNICEF) has remained at the forefront of battling starvation and malnutrition. This organization has recently created many awareness campaigns and humanitarian initiatives.
Impact of COVID-19 on North America Ready-to-use Therapeutic Food Market
The COVID-19 epidemic has increased the danger of malnourishment among the most vulnerable people in society. Due to government-mandated shutdowns, millions of people have lost their jobs, particularly in the agricultural industry, affecting crucial nutritional enhancement programs. In addition, due to lower immunity, extremely malnourished children are believed to be at an alarmingly greater risk of acquiring the new coronavirus. The same can be said about the elderly.
As a result, manufacturers are putting several measures to ensure that the supply of ready-to-use therapeutic foods is not impeded. As a result, sales have primarily remained stable throughout the pandemic and are expected to do so in the future.
Key Players
Major Players in the North America Ready-to-use Therapeutic Food Market are
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 1400
Didn’t find what you’re looking for?
TALK TO OUR ANALYST TEAM
Need something within your budget?
NO WORRIES! WE GOT YOU COVERED!
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: [email protected]
Reports By Region